777 related articles for article (PubMed ID: 26050111)
41. Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era.
Fairey AS; Daneshmand S; Skinner EC; Schuckman A; Cai J; Lieskovsky G
Urol Oncol; 2014 Feb; 32(2):85-91. PubMed ID: 24183191
[TBL] [Abstract][Full Text] [Related]
42. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
[TBL] [Abstract][Full Text] [Related]
43. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.
Mitchell CR; Boorjian SA; Umbreit EC; Rangel LJ; Carlson RE; Karnes RJ
BJU Int; 2012 Dec; 110(11):1709-13. PubMed ID: 22934913
[TBL] [Abstract][Full Text] [Related]
44. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
Rink M; Xylinas E; Margulis V; Cha EK; Ehdaie B; Raman JD; Chun FK; Matsumoto K; Lotan Y; Furberg H; Babjuk M; Pycha A; Wood CG; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF;
Eur Urol; 2013 Jun; 63(6):1082-90. PubMed ID: 22743166
[TBL] [Abstract][Full Text] [Related]
45. Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database.
Abern MR; Aronson WJ; Terris MK; Kane CJ; Presti JC; Amling CL; Freedland SJ
Prostate; 2013 Mar; 73(4):409-17. PubMed ID: 22996686
[TBL] [Abstract][Full Text] [Related]
46. Natural history of surgically treated high-risk prostate cancer.
Briganti A; Karnes RJ; Gandaglia G; Spahn M; Gontero P; Tosco L; Kneitz B; Chun FK; Zaffuto E; Sun M; Graefen M; Marchioro G; Frohneberg D; Giona S; Karakiewicz PI; Van Poppel H; Montorsi F; Joniau S;
Urol Oncol; 2015 Apr; 33(4):163.e7-13. PubMed ID: 25665508
[TBL] [Abstract][Full Text] [Related]
47. Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy.
Pagano MJ; Whalen MJ; Paulucci DJ; Reddy BN; Matulay JT; Rothberg M; Scarberry K; Patel T; Shapiro EY; RoyChoudhury A; McKiernan J; Benson MC; Badani KK
Prostate; 2016 Feb; 76(2):226-34. PubMed ID: 26481325
[TBL] [Abstract][Full Text] [Related]
48. Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.
Xylinas E; Kluth LA; Rieken M; Lee RK; Elghouayel M; Ficarra V; Margulis V; Lotan Y; Rouprêt M; Martinez-Salamanca JI; Matsumoto K; Seitz C; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF;
BJU Int; 2014 Jul; 114(1):56-61. PubMed ID: 24053463
[TBL] [Abstract][Full Text] [Related]
49. Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: a single-center 10-year report.
Li K; Li H; Yang Y; Ian LH; Pun WH; Ho SF
Chin Med J (Engl); 2011 Apr; 124(7):1001-5. PubMed ID: 21542957
[TBL] [Abstract][Full Text] [Related]
50. Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score.
Hansen J; Bianchi M; Sun M; Rink M; Castiglione F; Abdollah F; Steuber T; Ahyai SA; Steurer S; Göbel C; Freschi M; Montorsi F; Shariat SF; Fisch M; Graefen M; Karakiewicz PI; Briganti A; Chun FK
BJU Int; 2014 Mar; 113(3):399-407. PubMed ID: 24053339
[TBL] [Abstract][Full Text] [Related]
51. Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database.
Moreira DM; Antonelli JA; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
Urology; 2010 Nov; 76(5):1218-23. PubMed ID: 20381838
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.
Ahyai SA; Zacharias M; Isbarn H; Steuber T; Eichelberg C; Köllermann J; Fisch M; Karakiewicz PI; Huland H; Graefen M; Chun FK
BJU Int; 2010 Aug; 106(4):478-83. PubMed ID: 20128781
[TBL] [Abstract][Full Text] [Related]
53. Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.
Malik RD; Goldberg JD; Hochman T; Lepor H
Eur Urol; 2011 Sep; 60(3):548-53. PubMed ID: 21652145
[TBL] [Abstract][Full Text] [Related]
54. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes.
Mikel Hubanks J; Boorjian SA; Frank I; Gettman MT; Houston Thompson R; Rangel LJ; Bergstralh EJ; Jeffrey Karnes R
Urol Oncol; 2014 Jan; 32(1):26.e1-7. PubMed ID: 23395235
[TBL] [Abstract][Full Text] [Related]
55. Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study.
Mathieu R; Lucca I; Vartolomei MD; Mbeutcha A; Klatte T; Seitz C; Karakiewicz PI; Fajkovic H; Sun M; Lotan Y; Montorsi F; Briganti A; Rouprêt M; Margulis V; Rink M; Rieken M; Kenner L; Susani M; Wolgang L; Shariat SF
BJU Int; 2017 Feb; 119(2):234-238. PubMed ID: 26940243
[TBL] [Abstract][Full Text] [Related]
56. Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort.
Wadhwa H; Terris MK; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ; Abern MR
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):423-428. PubMed ID: 27698440
[TBL] [Abstract][Full Text] [Related]
57. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
[TBL] [Abstract][Full Text] [Related]
58. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer.
Oh JJ; Hong SK; Byun SS; Choe G; Lee SE
Urol Oncol; 2013 Jul; 31(5):595-600. PubMed ID: 21658977
[TBL] [Abstract][Full Text] [Related]
60. Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
Nagao K; Matsuyama H; Matsumoto H; Nasu T; Yamamoto M; Kamiryo Y; Baba Y; Suga A; Tei Y; Yoshihiro S; Aoki A; Shimabukuro T; Joko K; Sakano S; Takai K; Yamaguchi S; Akao J; Kitahara S;
Int J Clin Oncol; 2018 Aug; 23(4):757-764. PubMed ID: 29589154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
